Tectonic Therapeutic, Inc. (TECX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $413.27M
Last updated: Nov 17, 2026 at 11:05 AM ET
Tectonic Therapeutic, Inc. (TECX) Competitors
The companies most similar to Tectonic Therapeutic are Galectin Therapeutics (GALT), Tevogen Bio Holdings (TVGN) and Design Therapeutics (DSGN). By market cap, Tectonic Therapeutic ranks 7th of the 13 companies on this page; Design Therapeutics (DSGN) is the largest at $670.46M.
Peer Comparison
TECX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Tectonic Therapeutic (TECX) | $413.27M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Galectin Therapeutics Inc (GALT) | $307.59M | N/A | N/A | 0.0% | 671.1% | 0.0% | 0.00% |
| Tevogen Bio Holdings Inc. (TVGN) | $406.59M | N/A | N/A | 0.0% | 2022.8% | 0.0% | 0.00% |
| Design Therapeutics Inc (DSGN) | $670.46M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Shattuck Labs Inc (STTK) | $473.57M | N/A | N/A | 0.0% | N/A | -66.6% | 0.00% |
| Phathom Pharmaceuticals Inc (PHAT) | $492.63M | N/A | 1.8x | -30.2% | 11.4% | 71.1% | 0.00% |
| Contineum Therapeutics, Inc. Class A Common Stock (CTNM) | $387.16M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Gyre Therapeutics Inc. (GYRE) | $471.74M | N/A | 3.8x | -22.7% | N/A | 0.7% | 0.00% |
| Prothena Corporation plc (PRTA) | $419.01M | N/A | 7.8x | -45.4% | N/A | -74.3% | 0.00% |
| Bicycle Therapeutics Ltd (BCYC) | $236.22M | N/A | 2.7x | -169.8% | N/A | 190.2% | 0.00% |
| PepGen Ltd (PEPG) | $410.98M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Century Therapeutics Inc (IPSC) | $299.63M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Indaptus Therapeutics Inc (INDP) | $422.38M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $415.00M | N/A | 3.2x | 0.0% | 671.1% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Tectonic Therapeutic, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Galectin Therapeutics Inc (GALT) | Galectin Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of therapies for fibrotic... | GALT competitors |
| Tevogen Bio Holdings Inc. (TVGN) | Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology... | TVGN competitors |
| Design Therapeutics Inc (DSGN) | Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. | DSGN competitors |
| Shattuck Labs Inc (STTK) | Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapies for the treatment of cancer and autoimmune diseases in the United States. | STTK competitors |
| Phathom Pharmaceuticals Inc (PHAT) | Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. | PHAT competitors |
| Contineum Therapeutics, Inc. Class A Common Stock (CTNM) | Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies... | CTNM competitors |
| Gyre Therapeutics Inc. (GYRE) | Gyre Therapeutics Inc. is a pioneering biopharmaceutical company at the forefront of developing advanced therapies for rare and complex diseases. | GYRE competitors |
| Prothena Corporation plc (PRTA) | Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases... | PRTA competitors |
| Bicycle Therapeutics Ltd (BCYC) | Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. | BCYC competitors |
| PepGen Ltd (PEPG) | PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious... | PEPG competitors |
| Century Therapeutics Inc (IPSC) | Century Therapeutics Inc. (Ticker: IPSC) is a leading biotechnology company specializing in allogenic cell therapy... | IPSC competitors |
| Indaptus Therapeutics Inc (INDP) | Indaptus Therapeutics Inc. is a pioneering biotechnology firm focused on advancing immunotherapies that aim to transform cancer treatment paradigms. | INDP competitors |
Frequently Asked Questions About TECX
Who are Tectonic Therapeutic's main competitors?
The companies most similar to Tectonic Therapeutic include Galectin Therapeutics (GALT), Tevogen Bio Holdings (TVGN), Design Therapeutics (DSGN), Shattuck Labs (STTK) and Phathom Pharmaceuticals (PHAT), listed from the closest match.
Who is Tectonic Therapeutic's biggest competitor?
Design Therapeutics (DSGN) is the largest of the similar companies at $670.46M; Galectin Therapeutics (GALT) is the closest match by business profile, size, sector and industry.
How does TECX stock compare with its competitors?
TECX's net margin is 0.0% against a peer median of 0.0%.
Which of Tectonic Therapeutic's competitors pays a higher dividend?
Tectonic Therapeutic pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Tectonic Therapeutic bigger than its competitors?
No. Tectonic Therapeutic is 7th by market cap among the 13 companies on this page; the largest is Design Therapeutics (DSGN) at $670.46M.
TECX pages: Overview, Earnings, Forecast, Financials, Competitors